Levofloxacin/Loteprednol Etabonate

左氧氟沙星/氯替泼诺

Report date: 2025/11/14 13:46:49

Base Information

Drug NameLevofloxacin/Loteprednol Etabonate
Drug Alias NameLoteprednol Etabonate+Levofloxacin左氧氟沙星+氯替泼诺氯替泼诺+左氧氟沙星Loteprednol Etabonate/Levofloxacin氯替泼诺/左氧氟沙星 +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBacterial DNA gyrase inhibitorsGlucocorticoid receptor agonistsCytosolic phospholipase A2 agonists
TargetsTopoisomerase IIGlucocorticoid receptorCytosolic phospholipase A2 +[4] 
Therapy Area/IndicationsOcular inflammationEye Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Loteprednol EtabonateLevofloxacin
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShenyang Huatai Medication Research Co LtdShenzhen MingSight Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Huatai Medication Research Co LtdShenzhen MingSight Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsOcular inflammationEye Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A